A comprehensive description of the many ways in which TGFβ can inhibit antitumour immune responses through effects on innate and adaptive immune cells and how these immunosuppressive effects could be targeted for the benefit of patients with cancer.
- Richard A. Flavell
- Shomyseh Sanjabi
- Paula Licona-Limón